Literature DB >> 26046565

Updated, augmented vaccines compete with original antigenic sin.

Shraddha Chakradhar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26046565     DOI： 10.1038/nm0615-540

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

2.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

3.  Strategies to alleviate original antigenic sin responses to influenza viruses.

Authors:  Jin Hyang Kim; William G Davis; Suryaprakash Sambhara; Joshy Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

4.  13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccine.

Authors:  Robert Frenck; Allison Thompson; Shelly Senders; Laurie Harris-Ford; Malcolm Sperling; Scott Patterson; Carmel Devlin; Kathrin U Jansen; William C Gruber; Emilio A Emini; Daniel A Scott; Alejandra Gurtman
Journal:  Pediatr Infect Dis J       Date:  2014-02       Impact factor: 2.129
  4 in total
  5 in total

Review 1.  Polyvalent vaccines: High-maintenance heroes.

Authors:  Barbara Schlingmann; Katelyn R Castiglia; Christopher C Stobart; Martin L Moore
Journal:  PLoS Pathog       Date:  2018-04-05       Impact factor: 6.823

2.  Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.

Authors:  Lichen Jing; Kerry J Laing; Lichun Dong; Ronnie M Russell; Russell S Barlow; Juergen G Haas; Meena S Ramchandani; Christine Johnston; Soren Buus; Alec J Redwood; Katie D White; Simon A Mallal; Elizabeth J Phillips; Christine M Posavad; Anna Wald; David M Koelle
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

3.  An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World's Population.

Authors:  Andrés Felipe Cuspoca; Laura Lorena Díaz; Alvaro Fernando Acosta; Marcela Katherine Peñaloza; Yardany Rafael Méndez; Diana Carolina Clavijo; Juvenal Yosa Reyes
Journal:  Vaccines (Basel)       Date:  2021-06-01

4.  Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals.

Authors:  Juan Blanco-Heredia; Aarón Lecanda; Humberto Valenzuela-Ponce; Christian Brander; Santiago Ávila-Ríos; Gustavo Reyes-Terán
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

5.  SARS-CoV-2 vaccination in the context of original antigenic sin.

Authors:  Marek Petráš; Ivana Králová Lesná
Journal:  Hum Vaccin Immunother       Date:  2021-07-09       Impact factor: 3.452
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.